Stay updated on Tivozanib Plus Nivolumab in RCC: Clinical Trial
Sign up to get notified when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.

Latest updates to the Tivozanib Plus Nivolumab in RCC: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page. No core study content or functionality appears to be affected.SummaryDifference0.1%

- Check17 days agoChange DetectedPublications section updated to indicate automatic PubMed population and add Revision: v3.3.1; the previous wording referencing PubMed and Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check24 days agoChange DetectedRemoved the site-wide government funding and operating status notice from the page, including references to cc.nih.gov and opm.gov. The study content and details remain unchanged.SummaryDifference0.4%

- Check39 days agoChange DetectedNo significant changes to core study information; only presentational/UI adjustments are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedVersion label updated from v3.0.2 to v3.2.0.SummaryDifference0.1%

- Check69 days agoChange DetectedUpgrade of the page version from v3.0.2 to v3.1.0; a metadata/versioning change with no impact on core content or user-facing data.SummaryDifference0.1%

Stay in the know with updates to Tivozanib Plus Nivolumab in RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.